+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Renal Denervation Technologies - Global Market Trajectory & Analytics

  • ID: 5139957
  • Report
  • February 2022
  • Region: Global
  • 107 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories
  • Ablative Solutions, Inc.
  • Boston Scientific Corp.
  • Medtronic Inc
  • Mercator MedSystems, Inc.
  • ReCor Medical, Inc.

Global Renal Denervation Technologies Market to Reach $745.7 Million by 2026


Renal denervation refers to a catheter-based interventional therapy wherein a catheter is placed into a patient`s renal artery to make way for the delivery of radiofrequency energy in order to ablate the nerves in the vessel wall of the renal arteries that regulate vasoconstriction. Such a position leaves the vessel to continuously remain in the widest open position to enable higher flow of blood to the kidneys, allowing more blood to be filtered and excess water to be removed helping lower hypertension. The demand for renal denervation systems is growing steadily led by increase in prevalence of hypertension, growing base of geriatric population, longer lasting effect of the renal denervation procedure and its minimal complications and faster recovery time. Meanwhile, technological advancements are helping in the development of alternative technologies such as micro-infusion-based renal denervation systems. The demand of these systems is expected to grow as more clinical trials are conducted to establish efficacy and cost-effectiveness of renal denervation procedure as against traditional surgeries.

Amid the COVID-19 crisis, the global market for Renal Denervation Technologies estimated at US$113.3 Million in the year 2020, is projected to reach a revised size of US$745.7 Million by 2026, growing at a CAGR of 37.3% over the analysis period. Radiofrequency Based, one of the segments analyzed in the report, is projected to grow at a 36.8% CAGR to reach US$729.9 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ultrasound Based segment is readjusted to a revised 39.2% CAGR for the next 7-year period. This segment currently accounts for a 22.4% share of the global Renal Denervation Technologies market. Radiofrequency, owing to efficiency, safety and minimal time taken, is the most commonly used renal denervation technology with a dominating market share. Key factor favoring increase in demand for ultrasound-based renal denervation is its ability to overcome the shortcomings of radiofrequency-based renal denervation. The ultrasound-based technology uses high-frequency sound waves to ablates the nerves without establishing any contact with the tissues resulting in minimal injury to the renal arteries.



The U.S. Market is Estimated at $35.8 Million in 2021, While China is Forecast to Reach $49.5 Million by 2026


The Renal Denervation Technologies market in the U.S. is estimated at US$35.8 Million in the year 2021. The country currently accounts for a 25.46% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$49.5 Million in the year 2026 trailing a CAGR of 50.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 30.9% and 35.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 35.6% CAGR while Rest of European market (as defined in the study) will reach US$71.9 Million by the end of the analysis period. Europe dominates market share, driven by increasing number of drug-resistant hypertension cases, greater research and development initiatives for developing efficient devices, and approval of advanced renal denervation devices. Another key market, growth in the US is expected to be driven by escalating uncontrolled hypertension cases and increasing petitions for product authorizations.

Micro-Infusion Based Segment to Reach $38.1 Million by 2026


Micro-infusion based renal denervation focuses on delivering agents at a specific site to denervate the renal artery in order to reduce the blood pressure of the patient. As the approach involves direct and non-systemic injection of therapeutic agents, the method tends to be safe and more effective. In the global Micro-Infusion Based segment, USA, Canada, Japan, China and Europe will drive the 33.5% CAGR estimated for this segment. These regional markets accounted for a combined market size of US$5.8 Million in the year 2020. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.5 Million by the year 2026.

Select Competitors (Total 13 Featured) -

  • Medtronic Inc
  • Ablative Solutions, Inc.
  • Abbott Laboratories
  • Renal Dynamics Limited
  • Mercator MedSystems, Inc.
  • ReCor Medical, Inc.
  • Boston Scientific Corp.
  • Symple Surgical, Inc.
  • Terumo Corporation
Frequently Asked Questions about the Global Market for Renal Denervation Technologies

What is the estimated value of the Global Market for Renal Denervation Technologies?

The Global Market for Renal Denervation Technologies was estimated to be valued at $113.3 Million in 2020.

What is the growth rate of the Global Market for Renal Denervation Technologies?

The growth rate of the Global Market for Renal Denervation Technologies is 36.9%, with an estimated value of $745.7 Million by 2026.

What is the forecasted size of the Global Market for Renal Denervation Technologies?

The Global Market for Renal Denervation Technologies is estimated to be worth $745.7 Million by 2026.

Who are the key companies in the Global Market for Renal Denervation Technologies?

Key companies in the Global Market for Renal Denervation Technologies include Medtronic Inc, Ablative Solutions, Inc., Abbott Laboratories, Renal Dynamics Limited, Mercator MedSystems, Inc., ReCor Medical, Inc., Boston Scientific Corp. and Terumo Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Ablative Solutions, Inc.
  • Boston Scientific Corp.
  • Medtronic Inc
  • Mercator MedSystems, Inc.
  • ReCor Medical, Inc.

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Renal Denervation Technologies – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 13 Players Worldwide in 2022 (E)
  • Hypertension - A Chronic Disease
  • Impact of Covid-19 and a Looming Global Recession
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Covid-19 Causes Major Dent to a Growing Renal Denervation Technologies Market
  • A Prelude to Renal Denervation
  • The Evolution
  • Global Renal Denervation Technologies Market Set to Witness Rapid Growth
  • Developed Regions Dominate, Asia-Pacific Exhibits Fastest Growth
  • Europe – A Major Market
  • Radiofrequency Ablation Dominates the Market, Ultrasound to Register Fastest Growth
  • Radiofrequency Based Renal Denervation
  • Ultrasound Based Renal Denervation
  • Micro-Infusion Based Renal Denervation
  • Stringent Regulatory Environment
  • Growth Deterrents
  • Competitive Landscape
  • Select List of Approved Renal Denervation Devices
  • Symplicity Renal Denervation System Leads
  • Renal Denervation Devices
  • EnligHTN
  • Iberis
  • Paradise
  • Symplicity
  • Vessix (V2)
  • Recent Market Activity
  • Recent Clinical Trials in Nerve Denervation Technologies

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Increasing Incidence of Hypertension Drives the Market for Renal Denervation Technologies Market
  • Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
  • Ageing Demographics to Propel the Demand for Renal Denervation Devices
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Rising Obesity Incidence Spurs the Demand for Renal Denervation Technologies Market
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Uptrend in Healthcare Spending Creates Fertile Environment
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • Regulatory Approvals to Remain a Focal Point
  • Breakthrough Designations for Renal Denervation Devices

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World 7-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2021 & 2027
TABLE 3: World Recent Past, Current & Future Analysis for Radiofrequency Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 4: World 7-Year Perspective for Radiofrequency Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2021 & 2027
TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 6: World 7-Year Perspective for Ultrasound Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Micro-Infusion Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World 7-Year Perspective for Micro-Infusion Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 9: USA Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 10: USA 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

CANADA

TABLE 11: Canada Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 12: Canada 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

JAPAN

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 13: Japan Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 14: Japan 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

CHINA

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 15: China Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 16: China 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

EUROPE

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 17: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 18: Europe 7-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2021 & 2027
TABLE 19: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 20: Europe 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

FRANCE

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 21: France Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 22: France 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

GERMANY

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 23: Germany Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 24: Germany 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

ITALY

TABLE 25: Italy Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: Italy 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

UNITED KINGDOM

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 27: UK Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 28: UK 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

SPAIN

TABLE 29: Spain Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 30: Spain 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

RUSSIA

TABLE 31: Russia Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: Russia 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

REST OF EUROPE

TABLE 33: Rest of Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 34: Rest of Europe 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

ASIA-PACIFIC

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 35: Asia-Pacific Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 36: Asia-Pacific 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

LATIN AMERICA

  • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 37: Latin America Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Latin America 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

REST OF WORLD

TABLE 39: Rest of World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 40: Rest of World 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 13
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Medtronic Inc
  • Ablative Solutions, Inc.
  • Abbott Laboratories
  • Renal Dynamics Limited
  • Mercator MedSystems, Inc.
  • ReCor Medical, Inc.
  • Boston Scientific Corp.
  • Symple Surgical, Inc.
  • Terumo Corporation
Note: Product cover images may vary from those shown